Table 4. Comparison of effectiveness evaluation index scores between the two groups at mid-intervention (at 6 weeks of intervention) (ITT analysis)-Nantong, China, 2022.
Evaluation index | Control group | Intervention group | Statistics | P | |
---|---|---|---|---|---|
Adaptability to return to work ( ± s) | 85.67 ± 7.69 | 90.40 ± 10.23 | 1.433 | 0.164 | |
Return to work self-efficacy ( ± s) | 4.10 ± 0.51 | 4.33 ± 0.53 | –1.179 | 0.248 | |
Mental resilience ( ± s) | 65.13 ± 8.17 | 69.80 ± 7.95 | 1.586 | 0.124 | |
Ability to work ( ± s) | 28.37 ± 7.58 | 30.20 ± 7.75 | –0.746 | 0.462 | |
Quality of Life [M(P25,P75)] | Bodily function | 86.67(60.00, 100.00) | 93.33(73.33, 100.00) | –0.763 | 0.445 |
Role function | 83.33(50.00, 100.00) | 83.33(66.67, 100.00) | –0.428 | 0.669 | |
Emotional function | 83.33(66.67, 100.00) | 83.33(75.00, 100.00) | –0.557 | 0.578 | |
Cognitive function | 83.33(66.67, 100.00) | 100.00(66.67, 100.00) | –1.105 | 0.269 | |
Social function | 83.33(0.00, 100.00) | 83.33(33.33, 100.00) | –0.677 | 0.498 | |
Fatigue | 77.78(55.56, 100.00) | 77.78(66.67, 100.00) | –1.590 | 0.112 | |
Pain | 100.00(66.67, 100.00) | 100.00(33.33, 100.00) | –0.105 | 0.916 | |
Shortness of breath | 100.00(66.67, 100.00) | 100.00(66.67, 100.00) | –0.482 | 0.630 | |
Insomnia | 66.67(33.33, 100.00) | 66.67(33.33, 100.00) | –1.060 | 0.289 | |
Loss of appetite | 100.00(33.33, 100.00) | 100.00(66.67, 100.00) | –1.089 | 0.276 | |
Feel sick and vomit | 100.00(66.67, 100.00) | 100.00(83.33, 100.00) | –0.518 | 0.605 | |
Constipate | 100.00(66.67, 100.00) | 100.00(66.67, 100.00) | –0.598 | 0.550 | |
Diarrhea | 100.00(66.67, 100.00) | 100.00(100.00, 100.00) | –1.000 | 0.317 | |
Economic difficulties | 100.00(0.00, 100.00) | 100.00(0.00, 100.00) | –1.282 | 0.200 | |
General health | 66.67(50.00, 83.33) | 66.67(66.67, 83.33) | –1.705 | 0.088 |